Claim: Retatrutide is being tested for its potential effects on sleep apnea, diabetes, heart outcomes, and brain health.
Verdict: Partially True (60% confidence)
Explanation: According to clinicaltrials.gov and a study by K Giblin, retatrutide is being tested for its effects on sleep apnea, diabetes, and heart outcomes. These sources confirm that retatrutide is part of the TRIUMPH program, which assesses its efficacy for these conditions. However, no source explicitly mentions testing retatrutide for brain health, which means this part of the claim is not supported. Therefore, the claim is rated partially true, as the core components regarding sleep apnea, diabetes, ...